01
Agents work the queue
Agents handle portal work, corrections, calls, and follow-up so claims keep moving.
Oncology only. No recovery, no fee.
Stop losing $50,000
to denied claims.
One denied infusion can cost you that much.
We work every claim end to end. Your team just approves.
You can't lose money on this. Free 12-month audit in 2 business days. We only get paid from what we recover.
Oncology and infusion practices
AI-native recovery
AI works the queue. Experts handle the edge cases.
Active recovery queue
184 active claimsCO-197Auth expired$18,400
N569J-code correction$7,920
P12ASP variance$4,610
Payer policy
Clinical record
Portal action
02
RCM experts govern the edge cases
Specialists review high-dollar appeals, policy exceptions, and payer-specific arguments.
03
The system learns by payer
Outcomes feed the next queue so timing, evidence, and appeals get sharper by payer.
The oncology math
One denied infusion erases the margin on twenty successful ones.
Oncology runs buy-and-bill. Practices purchase chemotherapy and immunotherapy drugs with cash before a single claim goes out. Medicare Part B reimburses at ASP plus 6%, closer to 4.3% after sequestration. When a claim is denied, the practice doesn't lose profit. It loses the drug.
~$14,000
average denied claim in oncology
30–40%
of oncology denials caused by authorization gaps
4.3%
effective margin on Part B drugs after sequestration
Recovery estimate
Three numbers. One fast estimate.
Move the sliders to see what a year of denied infusion claims is worth to your practice.
Estimated annual recovery
$1,058,400
At risk
$3,024,000
Per month
$88,200
Estimate only. No PHI. A real audit replaces this with remit, payer, NDC, and filing-deadline data.
Request auditEnd-to-end recovery
Dievra works the claims your current workflows cannot reach.
Authorization lapse recovery
Treatment-level auth tracking with renewal triggers two cycles before expiration. The highest-dollar denial category, caught before it happens.
ASP underpayment detection
Every drug payment reconciled against the current quarter's ASP schedule. Underpayments are invisible in denial reports. We find them.
J-code claim correction
Unit calculations, NDC crosswalks, JW/JZ modifiers, and CPT administration pairings validated against HCPCS descriptors.
Appeals worked to outcome
Not drafted and forgotten. Pursued through payer portals, phone queues, and escalation until resolved.
Oncology only
Pay only on recovery
No cherry-picking
SOC 2 + HIPAA
Oncology only
Pay only on recovery
No cherry-picking
SOC 2 + HIPAA
Oncology only
Pay only on recovery
No cherry-picking
SOC 2 + HIPAA
Claims review, together
Human judgment where it matters most.
Revenue risk
Know what is worth working first.
Dievra turns remits into a short, human-ready recovery list.
How it works
What if claims actually kept moving?
01.
Connect
We integrate with your practice management and EHR system.
02.
Audit
We run twelve months of remits against ASP schedules and hand you a number before you commit.
03.
Work
AI agents pursue each claim through portals, corrections, and appeals.
04.
Recover
Payment posts to you. We invoice a percentage of what came back.
Request demo
Request a focused recovery demo.
Pick the conversation you want to have. We will show only the workflow, data, and claim logic relevant to that path.
Selected